Report cover image

TissueGen Inc - Product Pipeline Analysis, 2022 Update

Publisher GlobalData
Published Feb 07, 2023
Length 31 Pages
SKU # GBDT17776410

Description

Summary

TissueGen Inc (TissueGen) is a medical device company that develops fiber for advanced drug delivery, nerve regeneration and tissue engineering. The company’s products comprise of pharmaceutical fibers and growth factor fibers. It offers pharmaceutical fibers and growth factor fibers. TissueGen’s products are used in sciatic nerve repair, peripheral nerve regeneration, spinal cord repair, dermal wound healing and treatment of retinal disease among others. The company’s research and development department designs several fiber-based solutions which include anti-fibrillation devices, cardiovascular stents, nicotine-induced angiogenesis, ocular drug delivery and others. TissueGen is headquartered in Dallas, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company TissueGen Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

31 Pages
TissueGen Inc Company Overview
TissueGen Inc Company Snapshot
TissueGen Inc Pipeline Products and Ongoing Clinical Trials Overview
TissueGen Inc – Pipeline Analysis Overview
TissueGen Inc - Key Facts
TissueGen Inc - Major Products and Services
TissueGen Inc Pipeline Products by Development Stage
TissueGen Inc Pipeline Products Overview
Anti-Fibrillation Device
Anti-Fibrillation Device Product Overview
Archer Stent
Archer Stent Product Overview
Cardiovascular Stent
Cardiovascular Stent Product Overview
ELUTE Fiber - Diabetic Retinopathy
ELUTE Fiber - Diabetic Retinopathy Product Overview
ELUTE Fiber - Nicotine Induced Angiogenesis
ELUTE Fiber - Nicotine Induced Angiogenesis Product Overview
ELUTE Fiber - Peripheral Nerve Regeneration Scaffold
ELUTE Fiber - Peripheral Nerve Regeneration Scaffold Product Overview
ELUTE Fiber - Retinal Angiogenesis
ELUTE Fiber - Retinal Angiogenesis Product Overview
ELUTE Fiber - Smart Suture
ELUTE Fiber - Smart Suture Product Overview
ELUTE Fiber - Spinal Cord Injury Repair
ELUTE Fiber - Spinal Cord Injury Repair Product Overview
ELUTE Fiber - Urological Stent
ELUTE Fiber - Urological Stent Product Overview
TissueGen Inc - Key Competitors
TissueGen Inc - Key Employees
TissueGen Inc - Locations And Subsidiaries
Head Office
Recent Developments
TissueGen Inc, Recent Developments
Apr 16, 2018: Tissuegen Founder And Cso Dr. Kevin Nelson To Present “Enabling The Next Generation Of Drug Delivery Through Implantable Medical Devices” Session At Biomedevice Boston
Jan 17, 2018: TissueGen to Feature ELUTE Fiber for Advanced Drug Delivery, Nerve Regeneration and Tissue Engineering at MDM West
Sep 26, 2017: Edward Parent Appointed Director of Quality Assurance at TissueGen
Jun 05, 2017: Tissuegen to Highlight Elute Fiber for Advanced Drug Delivery, Nerve Regeneration and Tissue Engineering at MD&M East
Apr 19, 2017: TissueGen appoints New Faces for Growing Sales Team
Feb 27, 2017: TissueGen appoints new scientific advisory board member
Feb 27, 2017: Dr. Lisa A. Fortier Joins TissueGen's Scientific Advisory Board
Nov 07, 2016: TissueGen to Showcase ELUTE Fiber for Nerve Regeneration, Tissue Engineering and Advanced Drug Delivery at Neuroscience 2016
Mar 28, 2016: TissueGen Announces ISO13485:2003 Certification and Record Growth Driven by ELUTE Fiber
Dec 15, 2015: TissueGen's New ISO Class 7 Facility Supports FDA cGMP Drug Product Manufacturing
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: TissueGen Inc Pipeline Products and Ongoing Clinical Trials Overview
Table 2: TissueGen Inc Pipeline Products by Equipment Type
Table 3: TissueGen Inc Pipeline Products by Indication
Table 4: TissueGen Inc, Key Facts
Table 5: TissueGen Inc, Major Products and Services
Table 6: TissueGen Inc Number of Pipeline Products by Development Stage
Table 7: TissueGen Inc Pipeline Products Summary by Development Stage
Table 8: Anti-Fibrillation Device - Product Status
Table 9: Anti-Fibrillation Device - Product Description
Table 10: Archer Stent - Product Status
Table 11: Archer Stent - Product Description
Table 12: Cardiovascular Stent - Product Status
Table 13: Cardiovascular Stent - Product Description
Table 14: ELUTE Fiber - Diabetic Retinopathy - Product Status
Table 15: ELUTE Fiber - Diabetic Retinopathy - Product Description
Table 16: ELUTE Fiber - Nicotine Induced Angiogenesis - Product Status
Table 17: ELUTE Fiber - Nicotine Induced Angiogenesis - Product Description
Table 18: ELUTE Fiber - Peripheral Nerve Regeneration Scaffold - Product Status
Table 19: ELUTE Fiber - Peripheral Nerve Regeneration Scaffold - Product Description
Table 20: ELUTE Fiber - Retinal Angiogenesis - Product Status
Table 21: ELUTE Fiber - Retinal Angiogenesis - Product Description
Table 22: ELUTE Fiber - Smart Suture - Product Status
Table 23: ELUTE Fiber - Smart Suture - Product Description
Table 24: ELUTE Fiber - Spinal Cord Injury Repair - Product Status
Table 25: ELUTE Fiber - Spinal Cord Injury Repair - Product Description
Table 26: ELUTE Fiber - Urological Stent - Product Status
Table 27: ELUTE Fiber - Urological Stent - Product Description
Table 28: TissueGen Inc, Key Employees
Table 29: Glossary
List of Figures
Figure 1: TissueGen Inc Pipeline Products by Equipment Type
Figure 2: TissueGen Inc Pipeline Products by Development Stage

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us